Skip to main content

Table 1 Baseline characteristics of heart failure patients previously on furosemide (N = 232)

From: Torsemide versus furosemide after acute decompensated heart failure: a retrospective observational study

Characteristic

All Patients (N = 232) n (%)

Torsemide Users (N = 45) n (%)

Optimized Furosemide Users (N = 187), n (%)

P-value

Male Gender

126 (54.3)

24 (53.3)

102 (54.5)

0.88

Age*

67 ± 11.7

65 ± 10.7

67 ± 11.9

0.23

Weight*

83 ± 23.9

88 ± 24.3

82 ± 23.7

0.15

Heart Failure

   

0.23

 HFpEF

100 (43.1)

23 (51.1)

77 (41.2)

 

 HFrEF

132 (56.9)

22 (48.9)

110 (58.8)

 

Ejection Fraction

   

0.751§

  < 20%

8 (3.4)

2 (4.4)

6 (3.2)

 

 20–25%

38 (16.4)

10 (22.2)

28 (15.0)

 

 25–30%

32 (13.8)

4 (8.9)

28 (15.0)

 

 30–35%

32 (13.8)

3 (6.7)

29 (15.5)

 

 35–40%

22 (9.5)

3 (6.7)

19 (10.2)

 

 40–45%

25 (10.8)

7 (15.6)

18 (9.6)

 

 45–50%

30 (12.9)

5 (11.1)

25 (13.3)

 

  > 50%

45 (19.4)

11 (24.4)

34 (18.2)

 

Systolic Blood Pressure*

119 ± 18.2

120 ± 17.6

119 ± 18.3

0.92

Diastolic Blood Pressure*

67 ± 9.1

68 ± 9.5

67 ± 9.0

0.41

Heart Rate*

74 ± 12.8

74 ± 12.6

74 ± 12.9

0.87

Serum Potassium*

4.2 ± 0.46

4.15 ± 0.4

4.19 ± 0.47

0.55

Serum Creatinine*

137 ± 82.8

144 ± 64.3

135 ± 86.7

0.51

Creatinine Clearance*

61 ± 31.9

60 ± 27.9

61 ± 32.8

0.75

Serum Sodium*

137 ± 4.4

137 ± 4.8

137 ± 4.3

0.82

Baseline Furosemide (mg)*

66 ± 39

101 ± 47

57 ± 31

< 0.001

IV Furosemide

222 (95.7)

40 (88.9)

182 (97.3)

0.026

Concurrent Medical Conditions

 Atrial Fibrillation

70 (30.2)

17 (37.8)

53 (28.3)

0.22

 Coronary Artery Disease

158 (68.1)

24 (53.3)

134 (71.7)

0.018

 Hypertension

199 (85.8)

39 (86.7)

160 (85.6)

0.85

 Dyslipidemia

57 (24.6)

9 (20.0)

48 (25.7)

0.43

 Diabetes Mellitus

185 (79.7)

34 (75.6)

151 (80.7)

0.44

 Chronic Kidney Disease

99 (42.7)

22 (48.9)

77 (41.2)

0.35

 Mitral Regurgitation

46 (19.8)

12 (26.7)

34 (18.2)

0.2

 Mitral Stenosis

4 (1.7)

0 (0.0)

4 (2.1)

0.1

 Aortic Regurgitation

4 (1.7)

1 (2.2)

3 (1.6)

0.58

 Aortic Stenosis

14 (6)

4 (8.9)

10 (5.3)

0.48

 Tricuspid Regurgitation

29 (12.5)

8 (17.8)

21 (11.2)

0.23

 CABG

39 (16.8)

6 (13.3)

33 (17.6)

0.49

 PCI

82 (35.3)

12 (26.7)

70 (37.4)

0.18

 ICD

25 (10.8)

7 (15.6)

18 (9.6)

0.28

 CRTD

14 (6.0)

6 (13.3)

8 (4.3)

0.03

 Pacemaker

18 (7.8)

5 (11.1)

13 (7.0)

0.36

  1. *Values expressed as mean ± SD; P-value obtained through Fisher’s Exact test; §P-value obtained through Mann-Whitney test; HFpEF heart failure with preserved EF, HFrEF heart failure with reduced EF, CABG coronary artery bypass grafting, PCI percutaneous coronary intervention, ICD implantable cardioverter defibrillator, CRTD cardiac resynchronization therapy defibrillator